Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial
Sign Up to like & getrecommendations! Published in 2019 at "International Clinical Psychopharmacology"
DOI: 10.1097/yic.0000000000000251
Abstract: Clozapine is the only evidence-based antipsychotic for treatment-resistant schizophrenia. However, it has considerable side effects, limiting its usability and reducing patients’ adherence. One of the most common and distressing side effects is hypersalivation, which can… read more here.
Keywords: clozapine; placebo; induced hypersalivation; hypersalivation ... See more keywords